Oncopeptides presents new melflufen data at the Annual American Society of Hematology Meeting ASH
/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...
Source: prnewswire.com